For patients who are enrolled in private health insurance plans with copay accumulator programs, the value of third-party contributions—such as the value of manufacturer coupons or grants from charitable patient assistance foundations—don’t count toward patients’ deductibles or annual out-of-pocket limits. In this column for Pharmaceutical Commerce, PAN’s President and CEO, Kevin L. Hagan, and Chief … Continued
The PAN Foundation recently submitted a letter to the Centers for Medicare and Medicaid Services (CMS) with nearly five pages of detailed feedback about plans for the 2025 roll out of the Medicare Prescription Payment Plan. A total of 24 patient and provider organizations, including PAN, signed the letter, commenting on the implementation of the … Continued
The National Association of Specialty Pharmacy (NASP) named the PAN Foundation as their 2023 Strategic Channel Partner of the Year this week, announcing the award at their annual meeting and expo. “For nearly two decades, the PAN Foundation has provided a vital safety net for people who are underinsured and need financial assistance to cover … Continued
Charitable patient assistance foundations provide a critical lifeline to necessary healthcare for many across the U.S. At this year’s Healthcare Advocate Summit, PAN President and CEO Kevin L. Hagan spoke to Drug Topics about the importance of charitable foundations, Medicare reforms enacted through the Inflation Reduction Act, and why the need for charitable assistance will … Continued
Vanessa has held many monikers in her life. She spent thirteen years as Ms. Wyser-Pratte to her science students in New York City. For the last 11 years, she has been Super Auntie Vanessa, her favorite title. But her most recent label has been Vanessa the advocate. The California resident was diagnosed with rheumatoid arthritis … Continued
Health plan sponsors, like employers that fund their own health coverage, may use alternative funding programs (AFPs) to save money by excluding some or all specialty medications from coverage. But while they use AFPs to lower their costs, they are hurting the very patients they should be serving. In this column for Pharmaceutical Commerce, PAN’s … Continued
Bill grew up in historic Kentucky and spent much of his adult life living in Virginia. In 2015, he and his wife of nearly 50 years, Joline, moved to a retirement community in southern Maryland to be closer to family, especially his grandkids. Moving to a new area didn’t stop Bill from quickly putting down … Continued
The PAN Foundation today opened a new financial assistance program for people living with systemic lupus erythematosus, providing up to $6,300 per year for eligible patients. Systemic lupus erythematosus is the most common form of lupus. This autoimmune disease can cause inflammation and pain in multiple organs or organ systems, either acutely or chronically. The … Continued
The PAN Foundation today announced that they have become a member of the Global Genes Global Advocacy Alliance, working together to support the 400 million people living with a rare disease around the world. The Global Advocacy Alliance is a group of more than 600 nonprofit organizations and support groups who are committed to collaborating … Continued
The PAN Foundation today announced opposition to alternative funding programs, which jeopardize patient access to specialty medications and redirect finite charitable funds away from uninsured and underinsured patients. We urge Congress and the administration to learn about the growing use of alternative funding programs, understand their detrimental impact on patients, and evaluate options to discontinue … Continued
Subscribe to news
Sign up to receive PAN news, from helpful articles to action alerts.
Subscribe today